GENIX: Gene therapy & genome editing
Connect programme evidence to translation decisions.
View GENIXAdvanced Therapies Intelligence brings together the HERMS solutions that address one shared business problem within the governed HERMS life-sciences intelligence platform.
Complex translational evidence across gene therapy, cell therapy, exosomes and experimental design requires structured, traceable evaluation.
Connect programme evidence to translation decisions.
View GENIXConnect donor, process and patient-journey evidence.
View CELLIXAssess extracellular-vesicle evidence coherently.
View EXOGENIXMake experimental choices explicit and reviewable.
View EXIRIXAssess patient-centered product presentations.
View VESTIGOSolutions in this domain share evidence and governance with the rest of the HERMS platform, so decisions stay traceable and open to accountable human review. HERMS provides decision support and does not replace qualified professional, regulatory or clinical judgement.
Regulatory Intelligence Market Access Intelligence Patient Safety Intelligence Governance and Compliance Intelligence Manufacturing and Supply Intelligence Innovation and Investment Intelligence All HERMS solutions
ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.
We use essential cookies to run this website and, with your consent, analytics cookies to improve it. You can change your choice at any time. Cookie Policy · Privacy Policy
HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.